Skip to main content

Table 3 Toxic and adverse effects in the patients in the two groups (χ 2 ± s)

From: Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancer

Group   WBC (109/L) ALT (μ/L) Cr (μmol/L)
Group 1 Preoperative 6.82 + 0.85 27.32 + 12.12 2.31 + 0.42
Postoperative (one week) 8.95 + 1.23* 38.54 + 10.65** 2.54 + 0.43***
Group 2 Preoperative 5.98 + 0.79 24.75 + 13.68 2.33 + 0.61
Postoperative (one week) 9.05 + 2.12* 41.04 + 21.23** 2.53 + 0.71***
  1. Toxic effects in two groups are listed. When assessing hematologic toxicity, it was found that there were no significant differences in parameters like white blood cell (WBC) between the two groups (P > 0.05). No significant difference in creatinine, alanine aminotransferase (ALT)
  2. WBC white blood cell, ALT alanine aminotransferase, Cr creatinine
  3. No significant differences between the two groups, *P > 0.05, **P > 0.05, ***P > 0.05